MichaelJosephDiGiovannaDO

Clinical Trials

• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) Start of enrollment: 2005 Mar 01

  Completed

• Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy Start of enrollment: 2005 Jul 01

  Completed

  Phase 3

• A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus Start of enrollment: 2005 Jun 01

  Completed

  Phase 2

• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen Start of enrollment: 2006 Oct 04

  Completed

  Phase 4

• Amphotericin B Suspension in Refractory Chronic Sinusitis Start of enrollment: 2006 Dec 01

  Completed

  Phase 3

• Study of CB-183,315 in Participants With Clostridium Difficile Infection Start of enrollment: 2010 Apr 01

  Completed

  Phase 2

• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Start of enrollment: 2010 Jul 01

  Completed

  Phase 3

• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18

  Completed

  Phase 3

• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Start of enrollment: 2010 Oct 01

  Completed

  Phase 3

• Cardiovascular Inflammation Reduction Trial Start of enrollment: 2013 Apr 01

  Completed

  Phase 3

• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes Start of enrollment: 2012 Jun 01

  Completed

  Phase 3

• Longitudinal Study of Patients With Opioid-Induced Constipation Start of enrollment: 2012 Oct 01

  Completed

• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2024 Mar 29

  Recruiting

  Phase 2

  Roles: Principal Investigator

• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease Start of enrollment: 2024 Mar 05

  Recruiting

  Phase 2

  Roles: Principal Investigator

• Join now to see all